Medical News

RSS

Intuit combines Medfusion with Quicken Health Group

Intuit Inc. has transformed its healthcare business by combining newly acquired Medfusion with its Quicken Health Group to create a new business unit called Intuit Health. Based in Cary, N.C., the group is committed to improving healthcare through innovative online connected services that make the clinical, administrative, and financial side of healthcare easier for everyone.

26 Jul 2010

Gilead Sciences announces $2.2 billion convertible senior notes offering

Gilead Sciences, Inc. today announced its intention to offer, subject to market and other conditions, approximately $1.1 billion principal amount of convertible senior notes due 2014 and approximately $1.1 billion principal amount of convertible senior notes due 2016 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

26 Jul 2010

Tibotec submits NDA for TMC278 anti-HIV compound to FDA

Tibotec Pharmaceuticals today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for TMC278 (rilpivirine), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), being studied for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults. If approved, TMC278 will be the third anti-HIV compound to be introduced by Tibotec Pharmaceuticals.

26 Jul 2010

Insight Imaging acquires eight imaging centers

InSight Health Services Holdings Corp. today announced that it had completed the previously announced acquisition of eight imaging centers in the Phoenix, Arizona, El Paso, Texas, and Las Cruces, New Mexico areas from subsidiaries of MedQuest, Inc. and Novant Health, Inc.

26 Jul 2010

FDA grants Biovest's BiovaxID vaccine Orphan Drug Designation for mantle cell lymphoma

Biovest International, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BiovaxID®, Biovest's personalized cancer vaccine, for a second lymphoma indication: mantle cell lymphoma. Mantle cell lymphoma is an aggressive and lethal B-cell blood cancer for which there is no current consensus standard-of-care.

26 Jul 2010

Boston Scientific launches Neuroform EZ Stent System

Boston Scientific Corporation today announced the U.S. and European launches of the Neuroform EZ™ Stent System, its fourth-generation intracranial aneurysm stent system designed for use in conjunction with endovascular coiling to treat wide-necked aneurysms. The Company plans to launch the product immediately in both markets.

26 Jul 2010

AVEO's initiation of AV-299 Phase 2 trial for lung cancer triggers $750,000 milestone payment to XOMA

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced receipt of a $750,000 milestone payment under its collaboration with AVEO Pharmaceuticals, Inc.. The milestone payment resulted from AVEO's recent initiation of a Phase 2 clinical trial to evaluate its AV-299 antibody for the treatment of non-small cell lung cancer. AV-299 is a humanized antibody to hepatocyte growth factor (HGF).

26 Jul 2010

Researchers discover potential method for neurodegenerative disease detection

New investigations, initiated by research workers at CIC bioGUNE and led by Dr. Aitor Hierro, have opened possibilities for making progress in the knowledge and prediction of neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), according to the journal of The Proceedings of the National Academy of Sciences of the United States of America.This study opens the possibility of research in humans to detect this pathology before the symptoms arise.

26 Jul 2010

Orthovita's PMA supplement for new collagen processing facility receives FDA approval

Orthovita, Inc., an orthobiologics and biosurgery company, reported today that the U.S. Food and Drug Administration (FDA) approved Orthovita's PMA supplement for a new collagen processing facility in Malvern, Pennsylvania. Orthovita will use the new facility to process the highly purified form of collagen used in its VITAGEL™ Surgical Hemostat product. VITAGEL is a composite liquid hemostat used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.

26 Jul 2010

Onyx reports positive results from carfilzomib Phase 2b 003-A1 study in multiple myeloma

Onyx Pharmaceuticals, Inc. today announced positive top-line results from the Phase 2b 003-A1 study of single-agent carfilzomib, a selective, next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma.

26 Jul 2010

First Edition: July 26, 2010

Today's headlines include news about the politics of implementing the new health reform law as well as the ADA's 20th anniversary.

26 Jul 2010

BIO CEO and Pennsylvania Bio to discuss new Therapeutic Discovery Project Program

On Monday, July 26th, U.S. Rep. Allyson Schwartz, Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), and Christopher Molineaux, president of Pennsylvania Bio, will host a roundtable discussion on the new Therapeutic Discovery Project Program. This new program offers small biotech companies (less than 250 employees) a tax credit or grant to encourage investment in new medical therapies for life-changing diseases.

26 Jul 2010

Increase in need for language services increases revenues of ISI Translation Services

Even before the 2010 U.S. Census confirms it, one Los Angeles company's consistent growth throughout the recession reveals an increasing need for language services, especially for companies in the healthcare and financial services sectors.

26 Jul 2010

Vical's prophylactic Vaxfectin-formulated pDNA vaccine effective against HSV-2 in animal model

Vical Incorporated today announced that its prophylactic Vaxfectin®-formulated plasmid DNA (pDNA) vaccine against herpes simplex virus type 2 (HSV-2) protected mice against lethal challenge, provided sterilizing immunity and inhibited viral counts at both the primary and latent infection sites. The Vaxfectin® adjuvant substantially improved vaccine effectiveness. A related vaccine significantly reduced the recurrence of HSV-2 lesions in a therapeutic model using guinea pigs with latent infection.

26 Jul 2010

Hospital Dream Jobs website chosen #34 on 'Top 50 Nursing Job Sites Worth Bookmarking' list

Hospital Dream Jobs, a website focusing on hospital employment, medical careers, and healthcare jobs, was chosen #34 on a list of the "Top 50 Nursing Job Sites Worth Bookmarking" compiled by The Web Nurse, a leading blog for all things related to nursing jobs, healthcare, and the medical profession in general. This honor is especially significant given that Hospital Dream Jobs' website has only been live for six months, and is further validation of the effectiveness of the website's state-of-the-art services for both job seekers and employers in the medical profession.

26 Jul 2010

Analysis on link between visual number traits and abstract representations of correct letters

How does the brain link the visual basic traits of letters and numbers to abstract representations and to words? Scientists from the Basque Research Center on Cognition, Brain and Language have analyzed the influence of context on the visual recognition of a written word regardless of the format in which these letters may be displayed.We analyzed the influence of the context given by a word when linking the physical traits of its components to the abstract representations of letters,explains to SINC Nicola Molinaro, main author of the study and researcher of the Basque Research Center on Cognition, Brain and Language.

26 Jul 2010

Illumina launches TruSeq SBS Sequencing kit

Illumina, Inc. today announced the launch of its TruSeq SBS Sequencing kit that will enable high-quality paired end reads of 150 base pairs (bp), increase the output of high-quality base calls, and enhance throughput to greater than 95 Gigabases (Gb) of high-quality base pairs per run on Illumina's Genome Analyzer (GA) sequencing system.

From Illumina, Inc. 26 Jul 2010

Aptium Oncology to provide administrative services at new Beth Israel Comprehensive Cancer Center

Offering greater access to cancer care services for Manhattan West Side residents in New York, Beth Israel Medical Center has opened the Beth Israel Comprehensive Cancer Center - West Side Campus in the facility formerly known as St. Vincent's Comprehensive Cancer Center (SVCCC). The facility, which originally opened in 1996, was one of a few Saint Vincent's outpatient services units untouched and left open when the iconic hospital closed its doors on April 30, 2010. An official ribbon-cutting ceremony launched the center on Wednesday, July 14, 2010.

26 Jul 2010

Underwriters exercise over-allotment option in Uroplasty's common stock public offering

Uroplasty, Inc. announced today that the underwriters for the recently announced public offering of Uroplasty common stock have exercised in full their over-allotment option to purchase an additional 600,000 shares of the Company's common stock. The 4,600,000 shares of Uroplasty common stock in the offering, including the 600,000 shares subject to the over-allotment option, are being sold at a price to the public of $3.50 per share.

26 Jul 2010

Medtronic glucose monitoring device helps owners manage pets’ diabetes

The treatment of diabetes was revolutionized in 1922 when insulin was isolated from dogs. Since then, significant advances in human medicine have made diabetes more manageable for patients. Now, human medicine has returned the favor and used these advances to help dogs with diabetes. A University of Missouri researcher is using a continuous glucose monitoring device - commonly used in humans with diabetes - to help treat dogs and other animals. The device, which provides a detailed glucose picture of an animal over several days, will help pet owners manage their pets' diabetes.

26 Jul 2010

Medical News

Intuit combines Medfusion with Quicken Health Group

Gilead Sciences announces $2.2 billion convertible senior notes offering

Tibotec submits NDA for TMC278 anti-HIV compound to FDA

Insight Imaging acquires eight imaging centers

FDA grants Biovest's BiovaxID vaccine Orphan Drug Designation for mantle cell lymphoma

Boston Scientific launches Neuroform EZ Stent System

AVEO's initiation of AV-299 Phase 2 trial for lung cancer triggers $750,000 milestone payment to XOMA

Researchers discover potential method for neurodegenerative disease detection

Orthovita's PMA supplement for new collagen processing facility receives FDA approval

Onyx reports positive results from carfilzomib Phase 2b 003-A1 study in multiple myeloma

First Edition: July 26, 2010

BIO CEO and Pennsylvania Bio to discuss new Therapeutic Discovery Project Program

Increase in need for language services increases revenues of ISI Translation Services

Vical's prophylactic Vaxfectin-formulated pDNA vaccine effective against HSV-2 in animal model

Hospital Dream Jobs website chosen #34 on 'Top 50 Nursing Job Sites Worth Bookmarking' list

Analysis on link between visual number traits and abstract representations of correct letters

Illumina launches TruSeq SBS Sequencing kit

Aptium Oncology to provide administrative services at new Beth Israel Comprehensive Cancer Center

Underwriters exercise over-allotment option in Uroplasty's common stock public offering

Medtronic glucose monitoring device helps owners manage pets’ diabetes

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News